PDIAX
Price
$22.24
Change
+$0.12 (+0.54%)
Updated
Jul 3 closing price
Net Assets
136.07M
VVIAX
Price
$70.10
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

PDIAX vs VVIAX

Header iconPDIAX vs VVIAX Comparison
Open Charts PDIAX vs VVIAXBanner chart's image
Virtus KAR Equity Income A
Price$22.24
Change+$0.12 (+0.54%)
VolumeN/A
Net Assets136.07M
Vanguard Value Index Adm
Price$70.10
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
PDIAX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PDIAX vs. VVIAX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PDIAX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 189B vs. PDIAX (136M). PDIAX pays higher dividends than VVIAX: PDIAX (2.65) vs VVIAX (2.18). PDIAX was incepted earlier than VVIAX: PDIAX (28 years) vs VVIAX (25 years). PDIAX (1.12) is less costly to investors than VVIAX (0.05). PDIAX is a more actively managed with annual turnover of: 17.00 vs. VVIAX (9.00). PDIAX has a lower initial minimum investment than VVIAX: PDIAX (0) vs VVIAX (3000). PDIAX annual gain was more profitable for investors over the last year : 16.95 vs. VVIAX (12.03). VVIAX return over 5 years is better than : 80.13 vs. PDIAX (17.42).
PDIAXVVIAXPDIAX / VVIAX
Total Expense Ratio0.980.051,960%
Annual Report Gross Expense Ratio1.120.052,240%
Fund Existence28 years25 years-
Gain YTD9.7736.198158%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets136M189B0%
Annual Yield % from dividends2.652.18122%
Returns for 1 year16.9512.03141%
Returns for 3 years17.7935.1751%
Returns for 5 years17.4280.1322%
Returns for 10 years45.33115.6739%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAVA86.523.81
+4.61%
CAVA Group
ADTN9.560.16
+1.70%
ADTRAN Holdings
TWST38.170.49
+1.30%
Twist Bioscience Corp
ATMC11.84N/A
N/A
AlphaTime Acquisition Corp
SCNI2.20-0.07
-2.95%
Scinai Immunotherapeutics Ltd.